CLEVIPREX Side Effects

7023453-1 | Haemoglobin Decreased, Lower Gastrointestinal Haemorrhage, Rebound Tachycardia
on Mar 10, 2009 Male patient from UNITED STATES , 67 years of age, was diagnosed with hypertension and was treated with Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, lower gastrointestinal haemorrhage, rebound tachycardia. Cleviprex dosage: 2 Mg/hr And Double The Concentration To 4 Mg In 90 Seconds. During the same period patient was treated with LISINOPRIL (LISINOPRIL DIHYDRATE) (View Lisinopril (lisinopril Dihydrate) Review and Lisinopril (lisinopril Dihydrate) Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), FLOMAX (MORNIFLUMATE) (View Flomax (morniflumate) Review and Flomax (morniflumate) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ZANTAC (View Zantac Review and Zantac Label ), ZESTRIL (View Zestril Review and Zestril Label ).

6994954-7 | Gastrointestinal Haemorrhage, Haemoglobin Decreased, Procedural Hypertension
Patient was taking Cleviprex (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, procedural hypertension on Mar 27, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with hypertension and. Cleviprex dosage: 2mg/hr And Double The Concentration To 4 Mg In 90 Seconds , Next 24 Hrs Titrated From 6mg To 12 Mg. During the same period patient was treated with LISINOPRIL (LISINOPRIL DIHYDRATE) (View Lisinopril (lisinopril Dihydrate) Review and Lisinopril (lisinopril Dihydrate) Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), FLOMAX (MORNIFLUMATE) (View Flomax (morniflumate) Review and Flomax (morniflumate) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ZANTAC (View Zantac Review and Zantac Label ), ZESTRIL (View Zestril Review and Zestril Label ).

6866417-0 | Oxygen Saturation Decreased, Ventilation Perfusion Mismatch
Adverse event was reported on Mar 01, 2010 by a Female patient taking Cleviprex (View Usage) (Dosage: 1 Mg, Hr, Intravenous ; 2 Mg, Hr, Intravenous ; 4 Mg, Hr, Intravenous ; 2 Mg, Hr, Intravenous) was diagnosed with hypertension and. Location: UNITED STATES , 60 years of age, weighting 183.0 lb, After Cleviprex was administered, patient had the following side effects: oxygen saturation decreased, ventilation perfusion mismatch. During the same period patient was treated with VASOTEC (View Vasotec Review and Vasotec Label ), LANTUS (View Lantus Review and Lantus Label ), LISINOPRIL (LISINOPRIL DIHYDRATE) (View Lisinopril (lisinopril Dihydrate) Review and Lisinopril (lisinopril Dihydrate) Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6816286-X | Blood Pressure Inadequately Controlled, Procedural Complication, Subarachnoid Haemorrhage
on Jun 16, 2010 Male patient from UNITED STATES , 72 years of age, weighting 180.8 lb, was diagnosed with blood pressure management and was treated with Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, procedural complication, subarachnoid haemorrhage. Cleviprex dosage: 2 Mg, Hr, Intravenous; 3 Mg, Hr, Intravenous. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PROPOFOL (View Propofol Review and Propofol Label ), CISATRACURIUM (CISATRACURIUM) (View Cisatracurium (cisatracurium) Review and Cisatracurium (cisatracurium) Label ).


6673732-2 | Venous Thrombosis Limb
on Mar 18, 2010 Male patient from UNITED STATES , 72 years of age, weighting 174.2 lb, was diagnosed with haemorrhagic stroke, computerised tomogram and was treated with Cleviprex (View Usage). Patient had the following side effects: venous thrombosis limb. Cleviprex dosage: 16 Mg, Hr, Intravenous. During the same period patient was treated with CLEVIPREX (CLEVIDIPINE BUTYRATE) EMULSIONI FOR INFUSION, 0.5MG/ML (View Cleviprex (clevidipine Butyrate) Emulsioni For Infusion, 0.5mg/ml Review and Cleviprex (clevidipine Butyrate) Emulsioni For Infusion, 0.5mg/ml Label ), OPTIRAY 160 (150 Ml, Intravenous) (View Optiray 160 Review and Optiray 160 Label ).

6649810-0 | Agitation, Atrial Fibrillation, Colitis, Dyspnoea, Gastric Ulcer, Gastrointestinal Haemorrhage, Hypotension, Infusion Site Extravasation
Patient was taking Cleviprex (View Usage). After Cleviprex was administered, patient had the following side effects: agitation, atrial fibrillation (What is atrial fibrillation?), colitis, dyspnoea, gastric ulcer, gastrointestinal haemorrhage, hypotension, infusion site extravasation on Feb 12, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with blood pressure management and. Cleviprex dosage: 25mg Iv Titrate To Sbp 130-160, Bag #1 Forearm Proximal Rt, Intravenous. Patient was hospitalized.

6649796-9 | Agitation, Atrial Fibrillation, Blood Pressure Systolic Increased, Colitis, Diastolic Dysfunction, Dyspnoea, Gastric Ulcer, Gastrointestinal Haemorrhage
Adverse event was reported on Mar 05, 2010 by a Female patient taking Cleviprex (View Usage) (Dosage: 25 Mg Iv Titrate To Sbp 130-160, Bag #2 Forearm Proximal Rt, Intravenous) was diagnosed with blood pressure management and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: agitation, atrial fibrillation (What is atrial fibrillation?), blood pressure systolic increased, colitis, diastolic dysfunction, dyspnoea, gastric ulcer, gastrointestinal haemorrhage. Patient was hospitalized.

6645592-7 | Deep Vein Thrombosis, Infusion Site Erythema
on Mar 19, 2010 Male patient from UNITED STATES , weighting 174.2 lb, was diagnosed with blood pressure inadequately controlled, haemorrhagic stroke and was treated with Cleviprex (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), infusion site erythema. Cleviprex dosage: 16 Mg/hour Iv Drip. Patient was hospitalized.

6640274-X | Blood Pressure Inadequately Controlled, Underdose
on Nov 04, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with blood pressure increased and was treated with Cleviprex (View Usage). After Cleviprex was administered, patient had the following side effects: blood pressure inadequately controlled, underdose. Cleviprex dosage: See Image. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), TRILIPIX (FENOFIBRIC ACID) (View Trilipix (fenofibric Acid) Review and Trilipix (fenofibric Acid) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), DETROL LA (View Detrol La Review and Detrol La Label ), LISINOPRIL (LISINOPRIL DIHYDRATE) (View Lisinopril (lisinopril Dihydrate) Review and Lisinopril (lisinopril Dihydrate) Label ), NORVASC (View Norvasc Review and Norvasc Label ), FLOMAX (MORNIFLUMATE) (View Flomax (morniflumate) Review and Flomax (morniflumate) Label ).

6619242-X | Agitation, Atrial Fibrillation, Catheter Site Phlebitis, Colitis, Dyspnoea, Gastric Ulcer, Gastrointestinal Haemorrhage, Hypoalbuminaemia
Patient was taking Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, atrial fibrillation (What is atrial fibrillation?), catheter site phlebitis, colitis, dyspnoea, gastric ulcer, gastrointestinal haemorrhage, hypoalbuminaemia on Feb 12, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with blood pressure management and. Cleviprex dosage: See Image. Patient was hospitalized.

6569263-0 | Dyspnoea, Hypotension, Infusion Site Phlebitis, Product Quality Issue
Adverse event was reported on Feb 01, 2010 by a Female patient taking Cleviprex (View Usage) (Dosage: Initial Dose 1mg/hr Titrate Iv Dip) was diagnosed with hypertension and. Location: UNITED STATES , 80 years of age, weighting 164.2 lb, Patient had the following side effects: dyspnoea, hypotension, infusion site phlebitis, product quality issue.

6554457-0 | Acute Myocardial Infarction, Product Contamination Physical, Product Quality Issue
on Jan 25, 2010 Male patient from UNITED STATES , weighting 164.5 lb, was diagnosed with hypertension and was treated with Cleviprex (View Usage). After Cleviprex was administered, patient had the following side effects: acute myocardial infarction, product contamination physical, product quality issue. Cleviprex dosage: 100ml Prn Iv Drip.

6510503-1 | Infusion Site Induration, Infusion Site Pain, Infusion Site Pruritus, Infusion Site Swelling
on Dec 21, 2009 Male patient from UNITED STATES , weighting 215.4 lb, was diagnosed with hypertension and was treated with Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: infusion site induration, infusion site pain, infusion site pruritus, infusion site swelling. Cleviprex dosage: Iv. Patient was hospitalized.

6497685-5 | Oxygen Saturation Decreased, Respiratory Gas Exchange Disorder
Patient was taking Cleviprex (View Usage). Patient had the following side effects: oxygen saturation decreased, respiratory gas exchange disorder on Oct 02, 2009 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with blood pressure management, sedation and. Cleviprex dosage: 2 Mg. Hr, Intravenous, 6mg, Hr, 4 Mg, Hr, 2mg, Hr, 8 Mg, Hr. During the same period patient was treated with DEXMEDETOMIDINE HYDROCHLORIDE (View Dexmedetomidine Hydrochloride Review and Dexmedetomidine Hydrochloride Label ), PROPOFOL (View Propofol Review and Propofol Label ), CARDENE (View Cardene Review and Cardene Label ), ESMOLOL HCI (ESMOLOL HCI) (View Esmolol Hci (esmolol Hci) Review and Esmolol Hci (esmolol Hci) Label ).

6480335-1 | Renal Failure Acute
Adverse event was reported on Nov 16, 2009 by a Female patient taking Cleviprex (View Usage) (Dosage: 6 Ml, Hr, Intravenous) was diagnosed with blood pressure management and. Location: UNITED STATES , 76 years of age, After Cleviprex was administered, patient had the following side effects: renal failure acute.

6456639-5 | Cardiac Septal Defect Residual Shunt, Hypotension, Oxygen Saturation Decreased, Post Procedural Complication
on Nov 06, 2009 Male patient from UNITED STATES , 47 years of age, was diagnosed with procedural hypertension and was treated with Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac septal defect residual shunt, hypotension, oxygen saturation decreased, post procedural complication. Cleviprex dosage: Titrated From 1-2mg/hr Up To 32mg/hr, Intravenous. During the same period patient was treated with PARALYZING AGENT (View Paralyzing Agent Review and Paralyzing Agent Label ), CARDENE (View Cardene Review and Cardene Label ).

6436908-5 | Blood Pressure Decreased, Bradycardia, Carotid Artery Occlusion, Cerebrovascular Accident, Convulsion, Eye Rolling, Heart Rate Increased, Loss Of Consciousness, Respiratory Rate Decreased
on Oct 23, 2009 Male patient from UNITED STATES , 65 years of age, weighting 130.1 lb, was diagnosed with blood pressure increased and was treated with Cleviprex (View Usage). Patient had the following side effects: blood pressure decreased, bradycardia, carotid artery occlusion, cerebrovascular accident, convulsion, eye rolling, heart rate increased, loss of consciousness, respiratory rate decreased. Cleviprex dosage: Intravenous. During the same period patient was treated with WELCHOL (View Welchol Review and Welchol Label ), COZAAR (View Cozaar Review and Cozaar Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6409568-7 | Blood Amylase Increased, Lipase Increased
Patient was taking Cleviprex (View Usage). After Cleviprex was administered, patient had the following side effects: blood amylase increased, lipase increased on Oct 20, 2009 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 200.0 lb, was diagnosed with hypertension, sedation and. Cleviprex dosage: 2-14ml/hrs Weaned Iv Drip. During the same period patient was treated with PROPOFOL (15-20ml/hr Weaned Iv Drip) (View Propofol Review and Propofol Label ).

6408088-3 | Blood Pressure Decreased, Bradycardia, Carotid Artery Occlusion, Cerebrovascular Accident, Eye Rolling
Adverse event was reported on Oct 01, 2009 by a Male patient taking Cleviprex (View Usage) (Dosage: Intravenous) was diagnosed with blood pressure management and. Location: UNITED STATES , 65 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, bradycardia, carotid artery occlusion, cerebrovascular accident, eye rolling.

6408087-1 | Oxygen Saturation Decreased, Respiratory Gas Exchange Disorder
on Oct 02, 2009 Male patient from UNITED STATES , 45 years of age, was diagnosed with blood pressure management and was treated with Cleviprex (View Usage). Patient had the following side effects: oxygen saturation decreased, respiratory gas exchange disorder. Cleviprex dosage: 2 Mg, Hr ; Titrated To 21 Mg/hr ; 21 Mg, Hr. During the same period patient was treated with CARDENE (5 Mg, Hr ; 5 0 Mg/hr 15 Mg, Hr) (View Cardene Review and Cardene Label ).

6408086-X | Renal Failure Acute
on Oct 01, 2009 Female patient from UNITED STATES , 76 years of age, was diagnosed with blood pressure management and was treated with Cleviprex (View Usage). After Cleviprex was administered, patient had the following side effects: renal failure acute. Cleviprex dosage: 6 Ml, Hr, Intravenous.

6408084-6 | Oxygen Saturation Decreased, Respiratory Gas Exchange Disorder
Patient was taking Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: oxygen saturation decreased, respiratory gas exchange disorder on Oct 02, 2009 from UNITED STATES Additional patient health information: Male patient , 57 years of age, was diagnosed with blood pressure decreased, post procedural complication and. Cleviprex dosage: Around 1-3 Mg/hr, Intravenous.

6400928-7 | Blood Pressure Inadequately Controlled, Cardiac Failure Congestive, Dyspnoea, Fluid Overload, Incision Site Pain
Adverse event was reported on Sep 25, 2009 by a Female patient taking Cleviprex (View Usage) (Dosage: See Image) was diagnosed with hypertension and. Location: UNITED STATES , 49 years of age, Patient had the following side effects: blood pressure inadequately controlled, cardiac failure congestive, dyspnoea, fluid overload, incision site pain. During the same period patient was treated with HYDRALAZINE (HYDRALAZINE HYDROCHLORIDE) (View Hydralazine (hydralazine Hydrochloride) Review and Hydralazine (hydralazine Hydrochloride) Label ), HYDRALAZINE HCL (HYDRALAZINE HYDROCHLORIDE) (View Hydralazine Hcl (hydralazine Hydrochloride) Review and Hydralazine Hcl (hydralazine Hydrochloride) Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ZOSYN (View Zosyn Review and Zosyn Label ), VANCOMYCIN (VAMCOMYCIN) (View Vancomycin (vamcomycin) Review and Vancomycin (vamcomycin) Label ), TPN (View Tpn Review and Tpn Label ).

6357128-9 | Atrial Fibrillation
on Aug 24, 2009 Male patient from UNITED STATES , 65 years of age, weighting 184.3 lb, was diagnosed with coronary artery bypass (What is coronary artery bypass?) and was treated with Cleviprex (View Usage). After Cleviprex was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Cleviprex dosage: Intravenous.

6340161-0 | Blood Pressure Inadequately Controlled
on Aug 17, 2009 Male patient from UNITED STATES , 47 years of age, was diagnosed with blood pressure management, haemorrhage intracranial and was treated with Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled. Cleviprex dosage: 21 Mg, Hr, Intravenous. During the same period patient was treated with NICARDIPINE /00639802/ (NICARDIPINE HYDROCHLORIDE) (View Nicardipine /00639802/ (nicardipine Hydrochloride) Review and Nicardipine /00639802/ (nicardipine Hydrochloride) Label ).

6339131-8 | Infusion Site Erythema, Infusion Site Extravasation, Infusion Site Swelling, Infusion Site Warmth
Patient was taking Cleviprex (View Usage). Patient had the following side effects: infusion site erythema, infusion site extravasation, infusion site swelling, infusion site warmth on Jun 03, 2009 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with blood pressure management and. Cleviprex dosage: .

6339112-4 | Blood Glucose Increased
Adverse event was reported on Jun 15, 2009 by a Female patient taking Cleviprex (View Usage) (Dosage: 1 Mg, Hr, Intravenous; 1.5 Mghr; 2 Mg, Hr, Intravenous) was diagnosed with hypertension and. Location: UNITED STATES , 66 years of age, weighting 202.8 lb, After Cleviprex was administered, patient had the following side effects: blood glucose increased. During the same period patient was treated with DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER (D50/30kcl) (View Dextrose 5% And Potassium Chloride 0.075% In Plastic Container Review and Dextrose 5% And Potassium Chloride 0.075% In Plastic Container Label ), INSULIN (View Insulin Review and Insulin Label ), ANESTHETICS NOS (View Anesthetics Nos Review and Anesthetics Nos Label ), NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), NITRO /00003201/ (GLYCERYL TRINITRATE) (View Nitro /00003201/ (glyceryl Trinitrate) Review and Nitro /00003201/ (glyceryl Trinitrate) Label ), AMIKACIN (View Amikacin Review and Amikacin Label ).

6339032-5 | Nausea
on Jul 26, 2009 Female patient from UNITED STATES , 76 years of age, was diagnosed with blood pressure management and was treated with Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Cleviprex dosage: Intravenous.

6301282-1 | No Adverse Event
on Aug 05, 2009 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with hypertension and was treated with Cleviprex (View Usage). Patient had the following side effects: no adverse event. Cleviprex dosage: 1-2mg/hr, Titrate To Sbp90-130 Continous Iv Drip. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), VERSED (View Versed Review and Versed Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), NIPRIDE (View Nipride Review and Nipride Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6299591-8 | Cardiac Arrest, Hypertension
Patient was taking Cleviprex (View Usage). After Cleviprex was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypertension on Aug 05, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 167.0 lb, was diagnosed with hypertension and. Cleviprex dosage: 2mg/hr, Titrate To Sbp {150 Continuous Iv Drip. During the same period patient was treated with LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), COREG (View Coreg Review and Coreg Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ). Patient was hospitalized.

6299580-3 | No Adverse Event
Adverse event was reported on Aug 05, 2009 by a Female patient taking Cleviprex (View Usage) (Dosage: 1-2mg/hr, Titrate To Sbp140 Continuous Iv Dri[) was diagnosed with hypertensive crisis and. Location: UNITED STATES , weighting 121.0 lb, Patient experienced the following unwanted or unexpected effects: no adverse event. During the same period patient was treated with LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), NIPRIDE (View Nipride Review and Nipride Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

6274775-3 | Cerebrovascular Accident, Hypotension
on Jul 06, 2009 Male patient from UNITED STATES , 63 years of age, was diagnosed with blood pressure management and was treated with Cleviprex (View Usage). Patient had the following side effects: cerebrovascular accident, hypotension. Cleviprex dosage: 1 Mg, Hr, (titrated Up To A Max Of 8 Mg/hr), Intravenous. During the same period patient was treated with SODIUM NITROPRUSSIDE (View Sodium Nitroprusside Review and Sodium Nitroprusside Label ). Patient was hospitalized.

6249962-0 | Chills, Hypersensitivity, Hypotension, Pyrexia, Rash, Tremor, Vascular Resistance Systemic Decreased
on Jun 09, 2009 Male patient from UNITED STATES , 57 years of age, was diagnosed with blood pressure (What is blood pressure?) and was treated with Cleviprex (View Usage). After Cleviprex was administered, patient had the following side effects: chills, hypersensitivity, hypotension, pyrexia, rash (What is rash?), tremor, vascular resistance systemic decreased. Cleviprex dosage: 1mg/hr Intravenous, 2mg/hr, 3 Mg, Hr. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), BLOOD AND RELATED PRODUCTS (View Blood And Related Products Review and Blood And Related Products Label ), APAP(PARACETAMOL) (View Apap(paracetamol) Review and Apap(paracetamol) Label ).

6161722-8 | Cerebral Infarction, Hypertensive Crisis, Hypotension, Malaise, Mental Status Changes, Pupil Fixed
Patient was taking Cleviprex (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, hypertensive crisis, hypotension, malaise, mental status changes, pupil fixed on Apr 09, 2009 from UNITED STATES Additional patient health information: Male patient , 44 years of age, was diagnosed with hypertension and. Cleviprex dosage: 1-2mg, Hr, Intravenous; 4 Mg, Hr, Intravenous; 1-2mg, Hr. During the same period patient was treated with HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ).

6150854-6 | Blood Pressure Immeasurable, Hypertension, Hypotension, Malaise, Mydriasis, No Therapeutic Response
Adverse event was reported on Mar 25, 2009 by a Male patient taking Cleviprex (View Usage) (Dosage: 1-2 Mg, Hr, Intravenous; 4 Mg, Hr, Intravenous; 1-2 Mg, Hr) . Location: UNITED STATES , 44 years of age, Patient had the following side effects: blood pressure immeasurable, hypertension, hypotension, malaise, mydriasis, no therapeutic response. During the same period patient was treated with HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ).